查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1970180

2026-2034年全球子宫肌瘤治疗器械市场规模、份额、趋势和成长分析报告

Global Uterine Fibroid Treatment Device Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计子宫肌瘤治疗设备的市场规模将从 2025 年的 81.5 亿美元增长到 2034 年的 190.2 亿美元，并预计从 2026 年到 2034 年将以 9.87% 的复合年增长率增长。

随着微创疗法和先进介入技术的普及，子宫肌瘤治疗器械市场预计将持续成长。未来的器材将利用人工智慧辅助影像诊断、即时导航和机器人引导等技术，提高手术精准度、病患安全性和復原效果。与电子健康记录和远端监测的整合将优化治疗方案的发展和后续护理。

新兴技术包括先进的栓塞系统（可在最大限度减少创伤的同时提高疗效）、聚焦超音波设备和能量消融工具。结合预测分析技术，可实现个人化治疗方案的选择，从而优化患者疗效和资源利用。小巧、便携且符合人体工学设计的设备使其能够在门诊和诊所环境中得到更广泛的应用。

未来成长将得益于公众意识的提高、子宫肌瘤盛行率的上升以及微创治疗方法的广泛应用。透过结合精准仪器、人工智慧辅助规划和以患者为中心的照护模式，子宫肌瘤治疗方案将改善治疗效果、提升营运效率并提高医疗服务的可近性。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球子宫肌瘤治疗器材市场：依技术划分

  • 市场分析、洞察与预测
  • 手术治疗方法
  • 腹腔镜手术技术
  • 消融技术
  • 栓塞术

第五章：全球子宫肌瘤治疗器械市场：依治疗方法划分

  • 市场分析、洞察与预测
  • 侵入性治疗
  • 微创治疗
  • 非侵入性治疗

第六章 全球子宫肌瘤治疗器械市场：按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第八章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Medtronic
    • Stryker
    • Boston Scientific Corporation
    • Insightec
    • CooperSurgical Inc
    • Hologic Inc
    • Lumenis Be Ltd
    • Conmed Corporation
    • Gynesonics
    • Merit Medical Systems
简介目录
Product Code: VMR11213083

The Uterine Fibroid Treatment Device Market size is expected to reach USD 19.02 Billion in 2034 from USD 8.15 Billion (2025) growing at a CAGR of 9.87% during 2026-2034.

The uterine fibroid treatment device market is poised for growth as minimally invasive therapies and advanced interventional technologies gain adoption. Future devices will leverage AI-assisted imaging, real-time navigation, and robotic guidance to improve procedural accuracy, patient safety, and recovery outcomes. Integration with electronic medical records and remote monitoring will optimize treatment planning and follow-up care.

Emerging technologies include advanced embolization systems, focused ultrasound devices, and energy-based ablation tools that minimize invasiveness while enhancing efficacy. Integration with predictive analytics will guide personalized treatment selection, optimizing patient outcomes and resource utilization. Compact, portable, and ergonomically designed devices will enable broader access in outpatient and clinic settings.

Future growth will be driven by rising awareness, increasing prevalence of uterine fibroids, and adoption of minimally invasive treatment options. By combining precision devices, AI-assisted planning, and patient-centric care models, uterine fibroid treatment solutions will enhance procedural outcomes, operational efficiency, and healthcare accessibility.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

  • Surgical Techniques
  • Laparoscopic Techniques
  • Ablation Techniques
  • Embolization Techniques

By Mode of Treatment

  • Invasive Treatment
  • Minimally Invasive Treatment
  • Non-invasive Treatment

COMPANIES PROFILED

  • Medtronic, Stryker, Boston Scientific Corporation, Insightec, CooperSurgical Inc, Hologic Inc, Lumenis Be Ltd, Conmed Corporation, Gynesonics, Merit Medical Systems
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET: BY TECHNOLOGY 2022-2034 (USD MN and K Units)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. Surgical Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.3. Laparoscopic Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.4. Ablation Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.5. Embolization Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET: BY MODE OF TREATMENT 2022-2034 (USD MN and K Units)

  • 5.1. Market Analysis, Insights and Forecast Mode Of Treatment
  • 5.2. Invasive Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.3. Minimally Invasive Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.4. Non-invasive Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET: BY REGION 2022-2034(USD MN and K Units)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 6.2.1 By Technology
    • 6.2.2 By Mode Of Treatment
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 6.3.1 By Technology
    • 6.3.2 By Mode Of Treatment
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 6.4.1 By Technology
    • 6.4.2 By Mode Of Treatment
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 6.5.1 By Technology
    • 6.5.2 By Mode Of Treatment
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 6.6.1 By Technology
    • 6.6.2 By Mode Of Treatment
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL UTERINE FIBROID TREATMENT DEVICE INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Medtronic
    • 8.2.2 Stryker
    • 8.2.3 Boston Scientific Corporation
    • 8.2.4 Insightec
    • 8.2.5 CooperSurgical Inc
    • 8.2.6 Hologic Inc
    • 8.2.7 Lumenis Be Ltd
    • 8.2.8 Conmed Corporation
    • 8.2.9 Gynesonics
    • 8.2.10 Merit Medical Systems